Project Term
–
TBD
Project Summary
Auron Therapeutics is a platform-powered company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease. Auron pioneered its AURIGIN platform, which uses AI and machine learning to compare cell states and identify novel drug targets, optimal development models, and biomarkers to facilitate proper patient selection, ultimately accelerating the development of effective and durable therapies.
Lay Abstract
Program
Therapy Acceleration Program
Grant Subprogram
Biotechnology Accelerator